TG Therapeutics, Inc. (TGTX) — Analysis Summary
TG Therapeutics, Inc. (TGTX) has a market cap of $5.41B with year-over-year revenue growth of +40.8%. Net margin stands at 7.1%. The stock trades at a P/E ratio of 231.2.
Key Takeaways
- Revenue changed +40.8% year-over-year
- Net margin of 7.1%
- P/E ratio of 231.2
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, TGTX posted revenue growth of +40.8% and trades at a P/E of 231.2.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.